Dr. Robert S. Busch, M.D.
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- Perelman School of Med at the University of Pennsylvania (1978)
- Years since graduation
- 48
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 285
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1978Medical school: Perelman School of Med at the University of Pennsylvania
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
NY license 138424
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Albany Medical Center Hospital Albany, NY
Medical groups
- Albany Medical College (1,056 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 285
- Services billed
- 448
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 404 | 290 |
| Dxa bone density measurement of hip, pelvis, spine | 77 | 77 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 36 | 27 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Albany, NY | 652 |
| Jardiance (empagliflozin) Other prescribers in Albany, NY | 628 |
| Atorvastatin Calcium Other prescribers in Albany, NY | 603 |
| Ezetimibe Other prescribers in Albany, NY | 516 |
| Ozempic (semaglutide) Other prescribers in Albany, NY | 457 |
| Rosuvastatin Calcium Other prescribers in Albany, NY | 427 |
| Metformin Hcl Other prescribers in Albany, NY | 364 |
| Synthroid (levothyroxine sodium) Other prescribers in Albany, NY | 344 |
| Losartan Potassium Other prescribers in Albany, NY | 326 |
| Mounjaro (tirzepatide) Other prescribers in Albany, NY | 283 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 340 payments worth $356,820 in total to this clinician.
| Novo Nordisk Inc | $83,740 |
|---|---|
| Lilly USA, LLC | $55,141 |
| Corcept Therapeutics | $43,826 |
| Sanofi-aventis U.S. LLC | $42,193 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $35,674 |
| Madrigal Pharmaceuticals | $30,004 |
| Bayer HealthCare Pharmaceuticals Inc. | $24,559 |
| Ascendis Pharma Endocrinology Inc | $18,116 |
| Compensation for services other than consulting (speaking, faculty) | $261,999 |
|---|---|
| Travel and Lodging | $43,888 |
| Consulting Fee | $29,066 |
| Honoraria | $14,850 |
| Food and Beverage | $7,008 |
| Education | $7.70 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $9,204 |
| Novo Nordisk Inc Apr 23, 2025 | Consulting Fee Ozempic · Diabetes | $9,184 |
| Sanofi-aventis U.S. LLC Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $8,063 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $7,418 |
| Corcept Therapeutics Sep 10, 2025 | Honoraria Korlym · Endocrinology | $6,850 |
| Sanofi-aventis U.S. LLC Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $6,773 |
| Sanofi-aventis U.S. LLC Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $6,592 |
| Novo Nordisk Inc Aug 11, 2025 | Consulting Fee Ozempic · Diabetes | $6,161 |
| Ascendis Pharma Endocrinology Inc Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $5,664 |
| Corcept Therapeutics May 28, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $4,900 |
All 212 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Corcept Therapeutics Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $4,900 |
| Corcept Therapeutics Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $1,900 |
| Corcept Therapeutics Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $1,900 |
| Renalytix Ai, Inc. Dec 16, 2025 | Consulting Fee KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · INTERNAL MEDICINE | $1,600 |
| Madrigal Pharmaceuticals Dec 15, 2025 | Consulting Fee | $735 |
| Amgen Inc. Dec 12, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,500 |
| Corcept Therapeutics Dec 12, 2025 | Travel and Lodging Korlym · Endocrinology · travel to New Orleans, LA · in-kind | $853 |
| Corcept Therapeutics Dec 12, 2025 | Travel and Lodging Korlym · Endocrinology · travel to New Orleans, LA · in-kind | $611 |
| Amgen Inc. Dec 12, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $417 |
| Corcept Therapeutics Dec 12, 2025 | Travel and Lodging Korlym · Endocrinology · travel to New Orleans, LA | $24.00 |
| Madrigal Pharmaceuticals Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $2,695 |
| Corcept Therapeutics Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $1,900 |
| Corcept Therapeutics Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $1,900 |
| Chiesi USA, Inc. Dec 10, 2025 | Honoraria MYCAPSSA · ACROMEGALY | $325 |
| Madrigal Pharmaceuticals Dec 10, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to ALBANY, NY | $42.00 |
| Madrigal Pharmaceuticals Dec 8, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,430 |
| Madrigal Pharmaceuticals Dec 8, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to NEW HARTFORD, NY · in-kind | $2,002 |
| Renalytix Ai, Inc. Dec 8, 2025 | Consulting Fee KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · INTERNAL MEDICINE | $390 |
| Novo Nordisk Inc Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $2,674 |
| Novo Nordisk Inc Dec 4, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Bennington, VT · in-kind | $800 |
| Ascendis Pharma Endocrinology Inc Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $9,204 |
| Novo Nordisk Inc Nov 19, 2025 | Consulting Fee Multiple Therapeutic Areas | $1,628 |
| Novo Nordisk Inc Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $4,069 |
| Novo Nordisk Inc Nov 12, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Hudson, NY · in-kind | $756 |
| Corcept Therapeutics Nov 12, 2025 | Travel and Lodging Korlym · Endocrinology · travel to Miami, FL | $241 |
| Novo Nordisk Inc Nov 6, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Binghamton, NY · in-kind | $15.91 |
| Madrigal Pharmaceuticals Nov 4, 2025 | Consulting Fee REZDIFFRA · LIVER DISEASE | $1,960 |
| Eli Lilly and Company Oct 29, 2025 | Consulting Fee | $2,200 |
| Corcept Therapeutics Oct 24, 2025 | Travel and Lodging Korlym · Endocrinology · travel to New York, NY | $278 |
| Ascendis Pharma Endocrinology Inc Oct 22, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Portland, OR | $67.50 |
| Ascendis Pharma Endocrinology Inc Oct 22, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Portland, OR | $48.00 |
| Ascendis Pharma Endocrinology Inc Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $5,664 |
| Corcept Therapeutics Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $1,900 |
| Corcept Therapeutics Oct 9, 2025 | Travel and Lodging Korlym · Endocrinology · travel to Wray, CO · in-kind | $737 |
| Novo Nordisk Inc Oct 7, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $494 |
| Ascendis Pharma Endocrinology Inc Oct 7, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Portland, OR | $218 |
| Intra-sana Laboratories Oct 2, 2025 | Honoraria RELTONE 200 MG; GLYCATE; RELTONE 400 MG · GALLSTONES | $1,500 |
| Corcept Therapeutics Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $4,900 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $3,675 |
| Lilly USA, LLC Sep 29, 2025 | Travel and Lodging JARDIANCE · Diabetes · travel to ALBANY, NY | $7.00 |
| Corcept Therapeutics Sep 26, 2025 | Travel and Lodging Korlym · Endocrinology · travel to Miami, FL · in-kind | $799 |
| Corcept Therapeutics Sep 26, 2025 | Travel and Lodging Korlym · Endocrinology · travel to Miami, FL · in-kind | $343 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $1,490 |
| Corcept Therapeutics Sep 24, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $1,900 |
| Intra-sana Laboratories Sep 18, 2025 | Honoraria RELTONE 200 MG; GLYCATE; RELTONE 400 MG · GALLSTONES | $1,500 |
| Lilly USA, LLC Sep 17, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,100 |
| Lilly USA, LLC Sep 17, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $800 |
| Ascendis Pharma Endocrinology Inc Sep 17, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Portland, OR | $348 |
| Ascendis Pharma Endocrinology Inc Sep 17, 2025 | Travel and Lodging Yorvipath · Endocrinology · travel to Portland, OR | $348 |
| Corcept Therapeutics Sep 13, 2025 | Travel and Lodging Korlym · Endocrinology · travel to New York, NY · in-kind | $427 |
| Corcept Therapeutics Sep 13, 2025 | Travel and Lodging Korlym · Endocrinology · travel to New York, NY · in-kind | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 11, 2025 | Travel and Lodging JARDIANCE · DIABETES · travel to Shelton, CT · in-kind | $1,158 |
| Corcept Therapeutics Sep 10, 2025 | Honoraria Korlym · Endocrinology | $6,850 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,050 |
| Ascendis Pharma Endocrinology Inc Sep 3, 2025 | Compensation for services other than consulting (speaking, faculty) Yorvipath · Endocrinology | $2,124 |
| Madrigal Pharmaceuticals Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $1,225 |
| Novo Nordisk Inc Aug 14, 2025 | Consulting Fee Rybelsus · Diabetes | $1,604 |
| Novo Nordisk Inc Aug 13, 2025 | Consulting Fee Rybelsus · Diabetes | $1,604 |
| Novo Nordisk Inc Aug 13, 2025 | Consulting Fee Rybelsus · Diabetes | $1,070 |
| Novo Nordisk Inc Aug 11, 2025 | Consulting Fee Ozempic · Diabetes | $6,161 |
| Novo Nordisk Inc Aug 11, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Plainsboro, NJ · in-kind | $391 |
| Novo Nordisk Inc Aug 11, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Plainsboro, NJ · in-kind | $217 |
| Novo Nordisk Inc Aug 11, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Plainsboro, NJ · in-kind | $149 |
| Intra-sana Laboratories Aug 7, 2025 | Honoraria RELTONE 200 MG; GLYCATE; RELTONE 400 MG · GALLSTONES | $500 |
| Novo Nordisk Inc Aug 2, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $1,163 |
| Lilly USA, LLC Aug 1, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,050 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,050 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,675 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind | $602 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind | $244 |
| Madrigal Pharmaceuticals Jul 18, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DALLAS, TX · in-kind | $232 |
| Madrigal Pharmaceuticals Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $4,165 |
| Madrigal Pharmaceuticals Jun 27, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DURHAM, NC · in-kind | $712 |
| Madrigal Pharmaceuticals Jun 27, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to DURHAM, NC · in-kind | $286 |
| Madrigal Pharmaceuticals Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $3,430 |
| Madrigal Pharmaceuticals Jun 26, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to PRINCETON, NJ · in-kind | $1,560 |
| Madrigal Pharmaceuticals Jun 26, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to PRINCETON, NJ · in-kind | $507 |
| Madrigal Pharmaceuticals Jun 26, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to PRINCETON, NJ | $406 |
| Madrigal Pharmaceuticals Jun 26, 2025 | Travel and Lodging REZDIFFRA · LIVER DISEASE · travel to PRINCETON, NJ | $211 |
| Novo Nordisk Inc Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,836 |
| Novo Nordisk Inc Jun 24, 2025 | Travel and Lodging Ozempic · Diabetes · travel to New Bedford, MA · in-kind | $1,317 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,050 |
| Novo Nordisk Inc Jun 23, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,836 |
| Novo Nordisk Inc Jun 23, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orchard Park, NY · in-kind | $1,513 |
| Novo Nordisk Inc Jun 18, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $4,766 |
| Lilly USA, LLC Jun 18, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,050 |
| Novo Nordisk Inc Jun 18, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Cheshire, CT · in-kind | $221 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $4,098 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $2,980 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 11, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Auburn, NY · in-kind | $29.96 |
| Sanofi-aventis U.S. LLC Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $6,773 |
| Sanofi-aventis U.S. LLC Jun 10, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Fair Lawn, NJ · in-kind | $1,135 |
| Lilly USA, LLC Jun 9, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to TROY, NY | $42.00 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 7, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Oswego, NY · in-kind | $1,308 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 7, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Auburn, NY · in-kind | $833 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 7, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Auburn, NY · in-kind | $316 |
| Corcept Therapeutics Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $1,900 |
| Novo Nordisk Inc Jun 3, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $930 |
| Lilly USA, LLC Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,200 |
| Lilly USA, LLC Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,375 |
| Novo Nordisk Inc May 29, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,604 |
| Lilly USA, LLC May 29, 2025 | Travel and Lodging travel to WHITESBORO, NY · in-kind | $778 |
| Novo Nordisk Inc May 29, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Albany, NY · in-kind | $42.00 |
| Novo Nordisk Inc May 29, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Albany, NY · in-kind | $15.91 |
| Corcept Therapeutics May 28, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $4,900 |
| Lilly USA, LLC May 28, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,200 |
| Lilly USA, LLC May 28, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,375 |
| Novo Nordisk Inc May 28, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $930 |
| Lilly USA, LLC May 23, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Lilly USA, LLC May 22, 2025 | Travel and Lodging travel to NEW HARTFORD, NY · in-kind | $896 |
| Novo Nordisk Inc May 20, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $3,023 |
| Lilly USA, LLC May 19, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,200 |
| Lilly USA, LLC May 19, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,200 |
| Corcept Therapeutics May 19, 2025 | Travel and Lodging Korlym · Endocrinology · travel to Brooklyn, NY · in-kind | $1,390 |
| Lilly USA, LLC May 19, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,375 |
| Novo Nordisk Inc May 14, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $4,766 |
| Lilly USA, LLC May 14, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,200 |
| Lilly USA, LLC May 14, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,375 |
| Novo Nordisk Inc May 14, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Chappaqua, NY · in-kind | $1,297 |
| Lilly USA, LLC May 9, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Lilly USA, LLC May 9, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Novo Nordisk Inc May 9, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $930 |
| Novo Nordisk Inc May 8, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $930 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 7, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,050 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $506 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, NY · in-kind | $461 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $405 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $324 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $269 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $148 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $74.00 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $56.00 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $31.97 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $12.10 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $11.50 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $5.74 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.32 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind | $2.69 |
| Eli Lilly and Company May 7, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $2.49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 1, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,050 |
| Lilly USA, LLC May 1, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,050 |
| Novo Nordisk Inc Apr 30, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $4,766 |
| Intra-sana Laboratories Apr 30, 2025 | Honoraria RELTONE 200 MG; GLYCATE; RELTONE 400 MG · GALLSTONES | $1,500 |
| Novo Nordisk Inc Apr 30, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Nyack, NY · in-kind | $1,463 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $3,950 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $3,950 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,450 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,450 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 29, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,450 |
| Ascendis Pharma Endocrinology Inc Apr 29, 2025 | Education Yorvipath · Endocrinology · in-kind | $7.70 |
| Novo Nordisk Inc Apr 23, 2025 | Consulting Fee Ozempic · Diabetes | $9,184 |
| Novo Nordisk Inc Apr 23, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Coral Gables, FL · in-kind | $623 |
| Novo Nordisk Inc Apr 23, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Coral Gables, FL · in-kind | $608 |
| Novo Nordisk Inc Apr 23, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Coral Gables, FL · in-kind | $587 |
| Novo Nordisk Inc Apr 23, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Coral Gables, FL · in-kind | $28.00 |
| Novo Nordisk Inc Apr 22, 2025 | Consulting Fee Ozempic · Diabetes | $930 |
| Lilly USA, LLC Apr 21, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Lilly USA, LLC Apr 18, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to CAIRO, NY | $101 |
| Novo Nordisk Inc Apr 17, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $4,766 |
| Novo Nordisk Inc Apr 17, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Newburgh, NY · in-kind | $1,202 |
| Lilly USA, LLC Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,200 |
| Lilly USA, LLC Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $825 |
| Lilly USA, LLC Apr 15, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Lilly USA, LLC Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,050 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 4, 2025 | Travel and Lodging JARDIANCE · DIABETES · travel to Tulsa, OK · in-kind | $346 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 3, 2025 | Travel and Lodging JARDIANCE · DIABETES · travel to Tulsa, OK · in-kind | $2,829 |
| Corcept Therapeutics Apr 2, 2025 | Honoraria Korlym · Endocrinology | $2,675 |
| Lilly USA, LLC Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,200 |
| Lilly USA, LLC Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,375 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,050 |
| Novo Nordisk Inc Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $2,668 |
| Lilly USA, LLC Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,050 |
| Sanofi-aventis U.S. LLC Mar 26, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $4,193 |
| Sanofi-aventis U.S. LLC Mar 26, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Albany, NY | $49.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 25, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,050 |
| Lilly USA, LLC Mar 24, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,100 |
| Bayer HealthCare Pharmaceuticals Inc. Mar 15, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $4,843 |
| Bayer HealthCare Pharmaceuticals Inc. Mar 15, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Burlington, MA · in-kind | $1,290 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,050 |
| Sanofi-aventis U.S. LLC Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $6,592 |
| Sanofi-aventis U.S. LLC Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,296 |
| Sanofi-aventis U.S. LLC Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,884 |
| Lilly USA, LLC Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,050 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $7,418 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $3,675 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,050 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Lyndhurst, NJ · in-kind | $426 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Lyndhurst, NJ · in-kind | $421 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Lyndhurst, NJ | $60.00 |
| Sanofi-aventis U.S. LLC Mar 6, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Lyndhurst, NJ | $38.74 |
| Bayer HealthCare Pharmaceuticals Inc. Mar 5, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $4,098 |
| Lilly USA, LLC Mar 5, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,200 |
| Lilly USA, LLC Mar 5, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $2,200 |
| Lilly USA, LLC Mar 5, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,375 |
| Lilly USA, LLC Mar 3, 2025 | Travel and Lodging travel to ROME, NY · in-kind | $1,681 |
| Lilly USA, LLC Feb 28, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to ATLANTA, GA | $36.00 |
| Lilly USA, LLC Feb 28, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to ATLANTA, GA | $35.00 |
| Sanofi-aventis U.S. LLC Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) TZIELD · Endocrine & Metabolic Diseases | $8,063 |
| Sanofi-aventis U.S. LLC Feb 27, 2025 | Travel and Lodging TZIELD · Endocrine & Metabolic Diseases · travel to Louisville, KY | $28.00 |
| Lilly USA, LLC Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $1,575 |
| Lilly USA, LLC Feb 14, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes Company’s descriptionTHE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT. LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT. | $4,400 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Feb 12, 2025 | Travel and Lodging JARDIANCE · DIABETES · travel to Shelton, CT · in-kind | $748 |
| Lilly USA, LLC Feb 6, 2025 | Travel and Lodging travel to ATLANTA, NY · in-kind | $546 |
| Amgen Inc. Feb 5, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to ROCHESTER, NY · in-kind | $1,499 |
| Amgen Inc. Feb 4, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,500 |
| Amgen Inc. Feb 4, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $417 |
| Amgen Inc. Feb 4, 2025 | Travel and Lodging REPATHA · Cardiovascular · travel to LATHAM, NY | $49.00 |
| Amgen Inc. Jan 29, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $2,500 |
| Amgen Inc. Jan 29, 2025 | Compensation for services other than consulting (speaking, faculty) REPATHA · Cardiovascular | $417 |
| Bayer HealthCare Pharmaceuticals Inc. Jan 16, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $2,980 |
| Madrigal Pharmaceuticals Jan 13, 2025 | Compensation for services other than consulting (speaking, faculty) REZDIFFRA · LIVER DISEASE | $980 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 24 industry-funded studies in 2025, from 8 companies. The companies reported $874,281 in research payments for these studies, mostly to the institutions running them.
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Eli Lilly and Company · Active, not recruiting · NCT06292013 - A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Eli Lilly and Company · Active, not recruiting · NCT06662383 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
AbbVie Inc. · Active, not recruiting · NCT06345339 - A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy and safety of tirzepatide once weekly compared to placebo in adult participants with type 1 diabetes a…
Eli Lilly and Company - A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
Eli Lilly and Company · Active, not recruiting · NCT05556512 - A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Eli Lilly and Company · Completed · NCT04255433 - The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Eli Lilly and Company · Active, not recruiting · NCT06383390 - A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Eli Lilly and Company · Completed · NCT05872620 - Study name not reported
Novo Nordisk As - Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.